CDISC, HIMSS work to link patient care with clinical research

Laura Pedulli | | Health Exec | Precision Medicine

Clinical Data Interchange Standards Consortium (CDISC) and HIMSS, in partnership with Integrating the Healthcare Enterprise (IHE), are joining forces to solve the challenge of assessing and reusing EHR data for research purposes within a single workflow.

 

The goal will enable providers to “fully realize the important link between clinical research and patient care, paving the way for a learning health system,” according to a release.

 

CDISC has partnered with IHE on standards development, and has demonstrated interoperability capabilities at the HIMSS Interoperability Showcases. CDISC also has collaborated with IHE to develop ­­­nine IHE integration profiles for clinical research through the CDISC Healthcare Link Initiative.

 

Under the new Memorandum of Understanding, HIMSS and CDISC will launch additional activities focused on improving workflow, so clinicians can conduct prospective medical research using EHRs. Also, HIMSS will encourage the use of CDISC standards and EHR data for clinical research, and CDISC will support HIMSS strategic initiatives for advancing interoperability standards to achieve health IT integration. 

 

The two organizations will develop and disseminate information and standards documentation on the role of IHE profiles and CDISC standards in advancing clinical research, according to a release.

 

Learn more here. 

Laura Pedulli

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.